Storage & handling
Storage and handling of lyophilized peptides
Why storage temperature matters at all
Peptides degrade through several temperature-accelerated pathways: hydrolysis of peptide bonds, deamidation of asparagine/glutamine residues, oxidation of methionine/cysteine/tryptophan side chains, and aggregation. All of these reactions run faster at higher temperatures, which is the entire reason cold storage extends shelf life — it isn't a formality, it's slowing real chemistry.
This is also why storage isn't one-size-fits-all. The correct temperature depends on the specific compound's own stability profile, not a blanket rule applied to every lyophilized powder in a catalog.
Frozen, refrigerated, or room temperature — it depends on the compound
For genuinely unstable, tissue-derived, or rare bioregulator peptides, long-term frozen storage (typically minus 20 Celsius) is often the correct default, and some short synthetic peptides are explicitly stable at room temperature. But for a large share of research peptides, refrigeration at 2 to 8 Celsius — not freezing — is what manufacturer documentation and primary literature actually support, including for several widely used GLP-1-class compounds, where the approved commercial formulations are refrigerator-stable and explicitly should not be frozen.
Colder is always safer is a common assumption, but it isn't universally true: for some formulations, freeze-thaw cycling itself is the stress event that degrades the material, independent of absolute temperature. The specific compound's documented storage requirement — not a default frozen label applied uniformly across a catalog — is what should govern handling.
- Lyophilized (unreconstituted) powder: follow the specific compound's documented requirement — this varies by compound, not by a blanket rule.
- Reconstituted solution: as a general pattern, refrigeration and prompt use are more often appropriate than long-term frozen storage of an already-reconstituted solution, though the specific compound's own guidance should still govern.
- Protect from light: many peptides are photosensitive to some degree; amber vials or foil-wrapped storage reduce light exposure regardless of temperature.
Freeze-thaw cycling and reconstituted solutions
Repeated freezing and thawing of a reconstituted (liquid) solution is a distinct stress from steady-state cold storage — the physical process of ice crystal formation and the associated concentration changes at the ice-water interface can damage peptide structure and promote aggregation, even for a compound that tolerates being frozen once. This is why the general handling guidance is to aliquot a reconstituted solution into single-use portions rather than repeatedly freezing and thawing one larger volume.
Once reconstituted, most peptide solutions have a materially shorter usable window than the unreconstituted powder — commonly measured in days to a few weeks under refrigeration, not the months-to-years stability of the lyophilized form.
Signs a lyophilized powder may have degraded
Visual and physical cues worth checking before use include: discoloration (a shift toward yellow or brown from the expected white/off-white), a powder cake that has collapsed or shows signs of having been exposed to moisture, and — after reconstitution — persistent cloudiness or visible particulates rather than a clear solution. None of these definitively prove degradation on their own, but they're reasonable prompts to compare against the batch's own COA and, where in doubt, contact the supplier before use.